Amarantus effects capital restructuring in anticipation of national exchange listing
Amarantus BioSciences announced that it has implemented a 1-for-150 reverse stock split of its common stock. Trading on a split adjusted basis will occur upon final approval from FINRA. A new CUSIP number for the common shares will be issued in connection with the reverse split. May 22, 2015